-
Assessing sample representativeness in randomized clinical trials: Application to the National Institute of Drug Abuse Clinical Trials Network.
Susukida R, Crum RM, Stuart EA, Ebnesajjad C, Mojtabai R. Assessing sample representativeness in randomized clinical trials: Application to the National Institute of Drug Abuse Clinical Trials Network. Addiction 2016;111(7):1226-1234.
-
Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.
Murphy SM, Campbell ANC, Ghitza UE, Kyle TL, Bailey GL, Nunes DV, Polsky D. Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial. Drug and Alcohol Dependence 2016;161(1):119-126.
-
Gender differences in internalizing symptoms and suicide risk among men and women seeking treatment for cannabis use disorder from late adolescence to middle adulthood.
Foster KT, Li N, McClure EA, Sonne SC, Gray KM. Gender differences in internalizing symptoms and suicide risk among men and women seeking treatment for cannabis use disorder from late adolescence to middle adulthood. Journal of Substance Abuse Treatment 2016;66(1):16-22.
-
Examining longitudinal stimulant use and treatment attendance as parallel outcomes in two contingency management randomized clinical trials.
McPherson S, Brooks O, Barbosa-Leiker C, Lederhos C, Lamp A, Murphy S, Layton ME, Roll JM. Examining longitudinal stimulant use and treatment attendance as parallel outcomes in two contingency management randomized clinical trials. Journal of Substance Abuse Treatment 2016;61:18-25.
-
Evaluating nicotine craving, withdrawal, and substance use as mediators of smoking cessation in cocaine- and methamphetamine-dependent patients.
Magee JC, Lewis DF, Winhusen TJ. Evaluating nicotine craving, withdrawal, and substance use as mediators of smoking cessation in cocaine- and methamphetamine-dependent patients. Nicotine and Tobacco Research 2016;18(5):1196-1201.
-
Implementation of Network for the Improvement of Addiction Treatment (NIATx) processes in substance use disorder treatment centers.
Fields D, Knudsen HK, Roman PM. Implementation of Network for the Improvement of Addiction Treatment (NIATx) processes in substance use disorder treatment centers. Journal of Behavioral Health Services & Research 2016;43(3): 354-365.
-
On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users.
Northrup TF, Green C, Walker NR, Greer TL, Trivedi MH. On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users. Addictive Behaviors 2015;42: 144-147.
-
Comparison of two measures of HIV sexual risk behavior in women in outpatient drug treatment programs.
Thorens G, Pavlicova M, Hu MC, Nunes EV, Campbell ANC, Tross S. Comparison of two measures of HIV sexual risk behavior in women in outpatient drug treatment programs. J Addict Med 2015;9(6):454-456.
-
Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.
Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Experimental and Clinical Psychopharmacology 2015;23(6):428-435.
-
Substance use, depression and sociodemographic determinants of HIV sexual risk behavior in outpatient substance abuse treatment patients.
Tross S, Feaster DJ, Thorens G, Duan R, Gomez Z, Pavlicova M, Hu M, Kyle T, Erickson SJ, Spector AY, Haynes LF, Metsch LR. Substance use, depression and sociodemographic determinants of HIV sexual risk behavior in outpatient substance abuse treatment patients. Journal of Addiction Medicine 2015;9(6):457-463.